Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies John F. Paolini files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sanj K. Patel - $39.43M of KNSA open-market activity in the last 12 months
- Eben Tessari - $7.24M of KNSA open-market activity in the last 12 months
- Mark Ragosa - $3.78M of KNSA open-market activity in the last 12 months
- Michael R. Megna - $2.66M of KNSA open-market activity in the last 12 months
- Barry D. Quart - $1.85M of KNSA open-market activity in the last 12 months
- Ross Moat - $319K of KNSA open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is John F. Paolini?
John F. Paolini is a corporate insider, tracked as CHIEF MEDICAL OFFICER of Kiniksa Pharmaceuticals International, plc (KNSA). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did John F. Paolini last file a Form 4?
The most recent primary Form 4 on record is dated 5 May 2026, one of 7 filings going back to 2025.
Has John F. Paolini been buying or selling stock?
Recorded transactions: 0 open-market purchases and 7 open-market sales ($8.95M) across all tracked filings.
Where can I see all of John F. Paolini's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow John F. Paolini and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
